Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of the GSK Pandemic H1N1 Influenza Vaccines in Preventing Hospitalization for Influenza and Pneumonia in Manitoba, Canada

NCT01622491 is registered in ClinicalTrials.gov with International Centre for Infectious Diseases, Canada as lead sponsor.

NCT NCT01622491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01622491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of the GSK Pandemic H1N1 Influenza Vaccines in Preventing Hospitalization for Influenza and Pneumonia in Manitoba, Canada
Lead sponsor
International Centre for Infectious Diseases, Canada
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2012
Completion date
December 31, 2013
Enrollment
1,860 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, pneumonia